Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of British Columbia
$120,000.00
Precision-Driven Policy Modelling: Risk Based Lung Cancer Screening in Chronic Obstructive Pulmonary Disease
EF 2025-26
Résumé
Lung cancer is the leading cause of cancer death. One reason is that it's often found late, when treatments are less effective. Several Canadian provinces now run lung cancer screening programs to help find cancers earlier. These programs decide who to invite by estimating a person's risk of lung cancer. But risk patterns are changing-for example, rates are rising among some groups such as women and people who have never smoked-and current tools may miss people who would benefit.
People living with chronic obstructive pulmonary disease (COPD), a long-term lung condition, face a much higher chance of developing lung cancer. Yet today's screening tools were not built specifically for them. My research asks a simple question: would a lung cancer screening approach tailored to people with COPD work better than the "one-size-fits-all" method?
To find out, the study will:
Test and update a widely used lung cancer risk calculator so it more accurately predicts risk for people with COPD, using a large primary-care database.
Determine the best risk cutoff for offering screening, high enough to catch cancers early, but not so low that it causes unnecessary tests and worry.
Check whether this COPD-focused approach is good value for money in Canada by simulating different screening strategies and estimating earlier detections, deaths prevented, years of good health gained, and costs.
By sharpening who gets invited to screening, this research aims to reduce missed cancers, avoid unnecessary scans, save healthcare dollars, and lessen harms. The findings can directly support provincial and national policy decisions and, most importantly, promote more equitable access to and effective lung cancer care for Canadians at highest risk.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
560096
Name
Rezaeianzadeh Ramin
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Precision-Driven Policy Modelling: Risk Based Lung Cancer Screening in Chronic Obstructive Pulmonary Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Chronic Obstructive Pulmonary Disease; Cost-Effectiveness; Health Outcomes Research; Lung Cancer; Policy Modelling; Precision Medicine; Risk Prediction
Abstract
Lung cancer is the leading cause of cancer death. One reason is that it's often found late, when treatments are less effective. Several Canadian provinces now run lung cancer screening programs to help find cancers earlier. These programs decide who to invite by estimating a person's risk of lung cancer. But risk patterns are changing-for example, rates are rising among some groups such as women and people who have never smoked-and current tools may miss people who would benefit.
People living with chronic obstructive pulmonary disease (COPD), a long-term lung condition, face a much higher chance of developing lung cancer. Yet today's screening tools were not built specifically for them. My research asks a simple question: would a lung cancer screening approach tailored to people with COPD work better than the "one-size-fits-all" method?
To find out, the study will:
Test and update a widely used lung cancer risk calculator so it more accurately predicts risk for people with COPD, using a large primary-care database.
Determine the best risk cutoff for offering screening, high enough to catch cancers early, but not so low that it causes unnecessary tests and worry.
Check whether this COPD-focused approach is good value for money in Canada by simulating different screening strategies and estimating earlier detections, deaths prevented, years of good health gained, and costs.
By sharpening who gets invited to screening, this research aims to reduce missed cancers, avoid unnecessary scans, save healthcare dollars, and lessen harms. The findings can directly support provincial and national policy decisions and, most importantly, promote more equitable access to and effective lung cancer care for Canadians at highest risk.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rezaeianzadeh, Ramin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~